Piper Sandler Maintains Neutral on Dentsply Sirona, Raises Price Target to $14

Benzinga Newsdesk www.benzinga.com Neutral 66.1%

Neg 0% Neu 66.1% Pos 0%

Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and raises the price target from $13 to $14.